The Silent Shift: How Frequency Risk is Reshaping Accident & Health in 2026

Key Takeaways:

• Frequency risk refers to a growing number of high-cost claims rather than a single catastrophic event.
• In A&H markets, claims exceeding $2 million have increased significantly since 2020.
• Frequency risk can be harder to detect than severity risk because it develops gradually over time.
• Early detection of loss ratio deterioration, pricing lag, and fragmented data can help insurers respond more effectively.

Medical inflation continues to dominate discussions across Accident & Health markets. Across the healthcare reinsurance and medical stop loss sectors; however, a different challenge is beginning to emerge.

It is the steady rise of frequency risk.

While large, catastrophic claims still capture attention, the underlying challenge today is the increasing number and duration of claims breaching thresholds that were once considered exceptional. This is not a single dislocation event. It is a cumulative trend that, if left unaddressed, can quietly erode portfolio performance over time.

"The most significant threats to profitability are often the trends that become normalized and, in doing so, go unchallenged."

Why are claims patterns changing in Accident & Health insurance?

Historically, severity defined the outer limits of exposure. Today, those limits are being tested with increasing regularity. Since 2020, the frequency of multimillion-dollar medical claims has increased sharply across the medical stop-loss market, with several industry studies reporting significant growth in claims exceeding both $1 million and $2 million.

The significance of this trend is not simply that claims are growing larger. Healthcare has always produced high-cost claims. What is changing is the regularity with which they occur. Events that were once treated as outliers are increasingly appearing as recurring features of portfolio experience. That shift has important implications for pricing, capital allocation, and reinsurance strategy.

Several structural drivers and broader utilization trends are contributing to this shift, including increased NICU utilization,¹ rising rates of early-onset cancers,² and the continued expansion of advanced therapies such as gene and cell treatments.³

None of these developments are entirely new on their own. What makes today's environment different is their convergence. Earlier diagnosis, longer survival, advanced therapies, and higher utilization are interacting simultaneously. The result is not a temporary spike in claims activity, but a more fundamental change in how risk emerges and accumulates across the healthcare system.

Is medical innovation contributing to frequency risk?

There is a paradox at the center of this shift. Many of the forces driving frequency risk including innovation, earlier detection, and better treatment outcomes are positive indicators of progress.

At the same time, they introduce new underwriting complexities:

• Claims are lasting longer.
• Treatments are more expensive and increasingly continuous.
• More patients are crossing into higher-cost categories.

This is not an argument against medical innovation. Many of these developments may ultimately reduce long-term healthcare costs, improve patient outcomes, and extend lives. The challenge for today's market is that those benefits often emerge gradually, while the costs are incurred immediately and concentrated within current underwriting periods. Reinsurers and carriers must absorb those costs long before the broader economic benefits become visible.

For example, the median cost of a NICU hospitalization is $29,234, rising to $275,208 for extremely preterm infants.⁴ In oncology, certain chemotherapy regimes can cost more than $12,000 per month,⁵ while the growing cost of advanced therapies continues to place pressure on carriers and reinsurers. These costs are increasingly appearing within normal portfolio experience rather than as isolated events.

As frequency begins to intersect more regularly with severity, the traditional separation between these risk categories becomes less distinct.

Why is frequency risk harder to manage than severity risk?

Frequency risk behaves differently from severity. It is less visible, more distributed, and more gradual in its impact.

It typically:

• Sits within expected experience ranges.
• Accumulates over time rather than emerging as discrete events.
• Is obscured by data lag and reporting fragmentation.

As a result, pricing and portfolio adjustments often lag the underlying trend. By the time the impact is fully visible, earnings have already been affected.

In this environment, strategic focus shifts toward earnings protection and portfolio resilience.

How can frequency risk be identified earlier?

Frequency risk rarely presents as a single signal. It is identified through a pattern of indicators:

• Elevated loss ratios driven by cumulative claims activity.
• Pricing lag relative to emerging experience trends.
• Data lag across fragmented administrative structures.

Recognizing these signals early allows for proactive portfolio management, rather than reactive correction.

CALL OUT: A Frequency Risk Diagnostic Checklist

Frequency risk rarely appears as a single event. More often, it emerges through patterns that develop over time. Recognizing signals early enough to respond is key to ensure that trend does not become embedded in portfolio performance. Warning signs include:

• Loss Ratio Pressure
  Sustained deterioration without a single severity event often signals frequency-driven stress.
• Pricing Lag
  Claims trends begin moving faster than pricing adjustments, creating margin erosion.
• Data Lag and Fragmentation
  Delayed or inconsistent reporting can obscure emerging trends and delay corrective action.

A quieter, more consequential risk

The defining challenge for A&H in 2026 is not simply the increase in claims activity. It is the changing structure of that activity where medical inflation, treatment innovation, and utilization trends are converging.

Frequency risk is no longer a background factor. It is reshaping the economics of the market.

For participants in the healthcare reinsurance and medical stop loss markets, the more important consideration is whether the structures many organizations rely upon to manage risk are still aligned with how that risk is behaving. As frequency and severity begin to converge, traditional assumptions about reinsurance design deserve renewed scrutiny.

The most significant threats to profitability are not always the ones that stand out. Increasingly, they are the trends that become normalized and, in doing so, go unchallenged. Before organizations can decide how to respond, they first need to recognize that the nature of the risk itself has changed.